About Chris
Chris Murphy is the Chief Executive Officer of ElevateBio and a member of its Board of Directors. Chris brings more than 35 years of leadership, operational, and commercial experience across biopharmaceutical and manufacturing sectors.
Prior to ElevateBio, Chris served as Chief Executive Officer of Akron Bio, where he led a comprehensive transformation of the organization that drove robust revenue growth and valuation. Previously, he served as Chief Operating Officer of Brammer Bio, where he was responsible for the development and manufacture of viral vectors and led operations across four sites. The growth of the viral vector business led to the acquisition of Brammer Bio by Thermo Fisher Scientific in 2019, where Chris was responsible for integration and subsequently served as Vice President and General Manager of Viral Vector Services at Thermo Fisher. He has also held multiple leadership positions over his 16-year tenure at Sanofi Genzyme.
Education and Accomplishments
Chris holds a Master’s degree in Biochemistry from New York Medical College and a Bachelor of Science in Biological Sciences from Rutgers University. He also serves as Board President of West End House, a youth development organization supporting more than 1,500 Boston-area youth through outcomes-driven programs.
